Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

被引:0
|
作者
Yang, Chuting [1 ]
Zheng, Yaling [1 ]
Song, Chaoyang [2 ]
Wu, Ming [1 ]
Wang, Lei [1 ]
Zhou, Xuan [1 ]
Yue, Chunyan [1 ]
Lin, Xiaonan [1 ]
Chen, Jie [3 ]
Zeng, Hui [3 ]
Huang, Rui [1 ]
Li, Yuhua [2 ]
机构
[1] Southern Med Univ, Dept Hematol, Zhujiang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China
[3] Jinan Univ, Dept Hematol, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
D O I
10.1182/blood-2023-174879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Guillaume, Thierry
    Yakoub-Agha, Ibrahim
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Magro, Leonardo
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Mohty, Mohamad
    BLOOD, 2016, 128 (22)
  • [22] Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
    Lin, Chien-Ting
    Hsueh, Po-Ren
    Wu, Shang-Ju
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Hsu, Cheng-An
    Tang, Jih-Luh
    Tien, Hwei-Fang
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2310 - 2315
  • [23] Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia
    Huschart, Emily
    Miller, Holly
    Salzberg, Dana
    Campbell, Courtney
    Beebe, Kristen
    Schwalbach, Charlotte
    Magee, Kyrie
    Adams, Roberta H.
    Ngwube, Alexander
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (02) : 154 - 160
  • [24] Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Systematic Review
    Faisal, Muhammad Salman
    Hashim, Laila
    Samhouri, Yazan
    Abdullah, Syed Maaz
    Wahab, Ahsan
    Shahzad, Moazzam
    Ehsan, Hamid
    Ahmed, Zahoor
    Neupane, Karun
    Din, Asim Tameez Ud
    Anwer, Faiz
    Fazal, Salman
    BLOOD, 2020, 136
  • [25] Favorable Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Children With High-risk or Advanced Acute Myeloid Leukemia
    Koh, Kyung Nam
    Park, Meerim
    Kim, Bo Eun
    Bae, Keun Wook
    Im, Ho Joon
    Seo, Jong Jin
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (04) : 281 - 288
  • [26] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Thierry Guillaume
    Florent Malard
    Leonardo Magro
    Myriam Labopin
    Reza Tabrizi
    Cécile Borel
    Patrice Chevallier
    Stéphane Vigouroux
    Pierre Peterlin
    Alice Garnier
    Marie-Thérèse Rubio
    Anne Huynh
    Noël Milpied
    Philippe Moreau
    Béatrice Gaugler
    Ibrahim Yakoub-Agha
    Mohamad Mohty
    Bone Marrow Transplantation, 2019, 54 : 1815 - 1826
  • [27] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Guillaume, Thierry
    Malard, Florent
    Magro, Leonardo
    Labopin, Myriam
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Gaugler, Beatrice
    Yakoub-Agha, Ibrahim
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 (11) : 1815 - 1826
  • [28] Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia
    Craddock, Charles
    Labopin, Myriam
    Robin, Marie
    Finke, Juergen
    Chevallier, Patrice
    Yakoub-Agha, Ibrahim
    Bourhis, Jean Henri
    Sengelov, Henrik
    Blaise, Didier
    Luft, Thomas
    Hallek, Michael
    Kroeger, Nicolaus
    Nagler, Arnon
    Mohty, Mohamad
    HAEMATOLOGICA, 2016, 101 (07) : 879 - 883
  • [29] Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial
    Amit, Odelia
    Bar-On, Yael
    Perets, Galit
    Atlas, Lena
    Shargian, Liat
    Yeshurun, Moshe
    Yachini, Bruria
    Karni, Chen
    Ram, Ron
    BLOOD, 2019, 134
  • [30] Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia
    Ma, Yunju
    Qu, Changju
    Dai, Haiping
    Yin, Jia
    Li, Zheng
    Chen, Jia
    Qiu, Huiying
    Sun, Aining
    Miao, Miao
    Fu, Chengcheng
    Jin, Zhengming
    Zhu, Xiaming
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2019, 134